Cargando…
Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab
We report the case of a Jehovah's Witness adolescent patient with immune‐mediated thrombotic thrombocytopenic purpura after SARS‐Cov2 infection successfully treated without therapeutic plasma exchange (TPE) using caplacizumab, corticosteroids, rituximab, and extracorporeal immunoadsorption (EIA...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122792/ https://www.ncbi.nlm.nih.gov/pubmed/35600013 http://dx.doi.org/10.1002/ccr3.5902 |
| _version_ | 1784711420150022144 |
|---|---|
| author | Cardesa‐Salzmann, Teresa Marta Stephan, Bernhard Simon, Arne Furtwängler, Rhoikos Schöndorf, Dominik Heine, Sabine Torfah, Eyad Lux, Margaux Meyer, Sonja Graf, Norbert |
| author_facet | Cardesa‐Salzmann, Teresa Marta Stephan, Bernhard Simon, Arne Furtwängler, Rhoikos Schöndorf, Dominik Heine, Sabine Torfah, Eyad Lux, Margaux Meyer, Sonja Graf, Norbert |
| author_sort | Cardesa‐Salzmann, Teresa Marta |
| collection | PubMed |
| description | We report the case of a Jehovah's Witness adolescent patient with immune‐mediated thrombotic thrombocytopenic purpura after SARS‐Cov2 infection successfully treated without therapeutic plasma exchange (TPE) using caplacizumab, corticosteroids, rituximab, and extracorporeal immunoadsorption (EIA). Further patients for whom TPE is not an option might benefit from this approach. |
| format | Online Article Text |
| id | pubmed-9122792 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91227922022-05-21 Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab Cardesa‐Salzmann, Teresa Marta Stephan, Bernhard Simon, Arne Furtwängler, Rhoikos Schöndorf, Dominik Heine, Sabine Torfah, Eyad Lux, Margaux Meyer, Sonja Graf, Norbert Clin Case Rep Case Reports We report the case of a Jehovah's Witness adolescent patient with immune‐mediated thrombotic thrombocytopenic purpura after SARS‐Cov2 infection successfully treated without therapeutic plasma exchange (TPE) using caplacizumab, corticosteroids, rituximab, and extracorporeal immunoadsorption (EIA). Further patients for whom TPE is not an option might benefit from this approach. John Wiley and Sons Inc. 2022-05-20 /pmc/articles/PMC9122792/ /pubmed/35600013 http://dx.doi.org/10.1002/ccr3.5902 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Case Reports Cardesa‐Salzmann, Teresa Marta Stephan, Bernhard Simon, Arne Furtwängler, Rhoikos Schöndorf, Dominik Heine, Sabine Torfah, Eyad Lux, Margaux Meyer, Sonja Graf, Norbert Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab |
| title | Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab |
| title_full | Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab |
| title_fullStr | Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab |
| title_full_unstemmed | Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab |
| title_short | Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab |
| title_sort | immune‐mediated thrombotic thrombocytopenic purpura in a jehovah’s witness – effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122792/ https://www.ncbi.nlm.nih.gov/pubmed/35600013 http://dx.doi.org/10.1002/ccr3.5902 |
| work_keys_str_mv | AT cardesasalzmannteresamarta immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT stephanbernhard immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT simonarne immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT furtwanglerrhoikos immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT schondorfdominik immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT heinesabine immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT torfaheyad immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT luxmargaux immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT meyersonja immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab AT grafnorbert immunemediatedthromboticthrombocytopenicpurpurainajehovahswitnesseffectivenessofincorporatingextracorporealimmunoadsorptiontocaplacizumabsteroidsandrituximab |